Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians

American Journal of Cardiology

Volumn 82, Issue 3, 1998, Pages 299-305

  Gaudet, Daniel ^a   Vohl, Marie Claude ^b   Julien, Pierre ^b   Tremblay, Gérald ^b   Perron, Patrice ^b   Gagné, Claude ^b   Bergeron, Jean ^b   Moorjani, Sital ^b   Després, Jean Pierre ^b  

^a CHICOUTIMI HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; GENETIC RISK; HETEROZYGOSITY; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALLELES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; IMMUNOELECTROPHORESIS; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; QUEBEC; RECEPTORS, LDL; RETROSPECTIVE STUDIES;

EID: 0031904214     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00328-2     Document Type: Article

References (30)

1. Brown MS, Hobbs HH, Goldstein IL. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Diseases. 7 ed. New York: McGraw-Hill, 1995;1981-2030.
2. Vohl M-C, Moorjani S, Roy M, Gaudet D, Torres AL, Gagné C, Tremblay G, Couture P, Perrron P, Brun L-D, Davignon J, Lupien PJ, Després J-P. Geographical distribution of french canadian low-density lipoprotein receptor gene mutations in the province of Quebec. Clin Genet 1997;52:1-6.
3. Murthy V, Julien P, Gagné C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 1996;70:101-135.
4. Ma Y, Bétard C, Roy M, Davignon J, Kessling AM. Identification of a second French Canadian LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin Genet 1989;36:219-228.
5. Vohl MC, Couture P, Moorjani S, Torres AL, Gagné C, Després JP, Lupien PJ, Labrie F, Simard J. Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in french canadians. Hum Mutat 1995;6:243-246.
6. Couture P, Vohl MC, Gagné C, Gaudet D, Torres AL, Lupien PJ, Després JP, Labrie F, Simard J, Moorjani S. Identification of novel mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French-Canadians. Hum Mutat 1998(suppl I)S226-S231.
7. Bijvoet SM, Hayden MR. Mismatch PCR: a rapid method to screen for the Pro207→Leu mutation in the lipoprotein lipase (LPL) gene. Hum Mol Genet 1992;1:541.
8. Monsalve MV, Henderson H, Roederer G, Julien P, Deeb S, Kastelein JJP, Peritz L, Devlin R, Bruin T, Murthy MRV, Gagné C, Davignon J, Lupien PJ, Brunzell JD, Hayden MR. A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries. J Clin Invest 1990;86:728-734.
9. De Bruin TWA, Mailly F, Van Barlingen J, Fisher R, Castro Cabezas M, Talmud P, Dallinga-Thie GM, Humphries SE. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia. Eur J Clin Invest 1996;26:631-639.
10. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and anibody-bound peptids hormones in radioimmunoassays. J Clin Endocrinol Metab 1971;37:732-738.
11. Standardization of anthropometric measurements. In: Lohman T, Roche A. Martorel R, eds. The Airlie (VA) Consensus Conference. Human Kinetics 1988:39-80.
12. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8.
13. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28:1379-1387.
14. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Annal Biochem 1966;15:45-52.
15. Gaudet D, Vohl M-C, Perron P, Tremblay G, Gagné C, Lesiège D, Bergeron J, Moorjani S, Després J-P. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL-receptor gene. Circulation 1998;97:871-877.
16. Bétard C, Kessling AM, Roy M, Chamberland A, Lussier-Cacan S, Davignon J. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French-Canadians. Hum Genet 1992;88:529-536.
17. Patterson D, Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet 1972;747:393-399.
18. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-1568.
19. Nikkilä EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet 1973;1:954-959.
20. Koivisto U-M, Hämäläinen L, Taskinen M-R, Kettunen K, Kontula K. Prevalence of familial hypercholesterolemia among young North Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction. J Lipid Res 1993;24:269-277.
21. Vohl MC, Gaudet D, Moorjani S, Tremblay G, Perron P, Gagné C, Lesiège D, Bergeron J, Lupien PJ, Després JP. Comparison of the effect of two low-density-lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia. Eur J Clin Invest 1997;27:366-373.
22. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (Prospective results from the Quebec cardiovascular study). Am J Cardiol 1995;75:1189-1195.
23. Després JP, Lamarche B, Maurìge P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-957.
24. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mantarri M, Heinonen O, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study: implications for treatment. Circulation 1992;85:37-45.
25. Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 1989;9:326-334.
26. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-2048.
27. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int J Clin Lab Res 1997;27:24-34.
28. Jukema JW, van Boven AJ, Groenemeijer B, Zwinderman AH, Reiber JH, Bruschke AV, Henneman JA, Molhoek GP, Bruin T, Jansen H, Gagne E, Hayden MR, Kastelein JJ. The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation 1996;94:1913-1918.
29. Reymer PW, Gagné E, Gronemeyer BE, Zhang H, Forsyth I, Jansen H, Seidell JC, Kromhout D, Lie KE, Kastelein J, et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 1995;10:28-34.
30. Julien P, Vohl M-C, Gaudet D, Gagné C, Lévesque G, Després J-P, Cadelis F, Brun LD, Nadeau A, Ven Murthy MR. Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency. Diabetes 1997;46:2063-2068.